Skip to main content
Clinical Trials/ISRCTN56202806
ISRCTN56202806
Active, not recruiting
未知

The use of portable magnetoencephalography (MEG) in movement disorders

niversity of Oxford0 sites75 target enrollmentJanuary 16, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Essential tremor
Sponsor
niversity of Oxford
Enrollment
75
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2020
End Date
March 1, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with Essential Tremor without DBS implants for standard clinical indications
  • 2\. Patients with Parkinson's disease and tremor dominant without DBS implants for standard clinical indications
  • 3\. Patients with Parkinson's disease and non\-tremor dominant without DBS implants for standard clinical indications
  • 4\. Patients with Dystonic tremor without DBS implants for standard clinical indications
  • 5\. Patients between 25 \- 80 years of age
  • 6\. Patients have the capacity to give informed consent
  • 7\. Patients are MRI safe \- i.e. no metal implants, history of working in metal industry etc

Exclusion Criteria

  • 1\. Cognitive impairment (judged by the clinician taking consent as not having sufficient mental capacity to understand
  • the study and its requirements). This is including anyone who, in the opinion of the clinician taking consent is unlikely
  • to retain sufficient mental capacity for the duration of their involvement in the study
  • 2\. Pregnancy
  • 3\. Severe claustrophobia
  • 4\. Head or neck muscle weakness/fatigue
  • 5\. Severe visual impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials